Structural accelerated failure time models for survival analysis in studies with time-varying treatments
- 1 July 2005
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 14 (7) , 477-491
- https://doi.org/10.1002/pds.1064
Abstract
Background In the absence of unmeasured confounding factors and model misspecification, standard methods for estimating the causal effect of time‐varying treatments on survival are biased when (i) there exists a time‐dependent risk factor for survival that also predicts subsequent treatment and (ii) past treatment history predicts subsequent risk factor level. In contrast, structural models provide consistent estimates of causal effects when unmeasured confounding and model misspecification are absent. The parameters of nested structural models are estimated by g‐estimation and those of marginal structural models by inverse probability weighting. Methods We describe a nested structural accelerated failure time model and use it to estimate the total causal effect of highly active antiretroviral therapy (HAART) on the time to AIDS or death among human immunodeficiency virus (HIV)‐infected participants of the Multicenter AIDS Cohort and Women's Interagency HIV Studies. The Appendix describes g‐estimation and methods to deal with censoring. Results Comparing the regime ‘always treated’ to ‘never treated,’ the AIDS‐free survival time ratio was 2.5 (95% confidence interval [CI]: 1.7, 3.3). Conclusions Our finding of a strongly beneficial effect is consistent with results from randomized trials and from a previous analysis of the same data using a marginal structural Cox model. In contrast, a previous analysis using a standard (non‐structural) model did not find an effect of treatment on survival. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- A Structural Approach to Selection BiasEpidemiology, 2004
- Effect of Highly Active Antiretroviral Therapy on Time to Acquired Immunodeficiency Syndrome or Death using Marginal Structural ModelsAmerican Journal of Epidemiology, 2003
- Fallibility in estimating direct effectsInternational Journal of Epidemiology, 2002
- Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized TreatmentsJournal of the American Statistical Association, 2001
- The Womenʼs Interagency HIV StudyEpidemiology, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- A method for the analysis of randomized trials with compliance information: An application to the multiple risk factor intervention trialControlled Clinical Trials, 1993
- Estimation of the time-dependent accelerated failure time model in the presence of confounding factorsBiometrika, 1992
- THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTSAmerican Journal of Epidemiology, 1987
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effectMathematical Modelling, 1986